Y08284
Y08284 is a potent, selective, oral active CBP bromodomain inhibitor with an IC50 of 4.21 nM. Y08284 suppresses the proliferation of prostate cancer cell lines LNCaP, C4-2B, and 22Rv1. Antitumor activity.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2688745-47-1
- Formule: C26H25FN4O4
- Masse moléculaire:476.50
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| CWR22R | IC50 |
2.04 μM
Compound: 9g; Y08284
|
Antiproliferative activity against human 22Rv1 cells assessed as cell growth inhibition by Celltiter-Glo assay
Antiproliferative activity against human 22Rv1 cells assessed as cell growth inhibition by Celltiter-Glo assay
|
[PMID: 34962793] |
| LNCaP | IC50 |
0.59 μM
Compound: 9g; Y08284
|
Antiproliferative activity against human LNCaP cells assessed as cell growth inhibition by Celltiter-Glo assay
Antiproliferative activity against human LNCaP cells assessed as cell growth inhibition by Celltiter-Glo assay
|
[PMID: 34962793] |
| LNCaP C4-2B | IC50 |
6.43 μM
Compound: 9g; Y08284
|
Antiproliferative activity against human LNCaP C4-2B cells assessed as inhibition of cell growth by Celltiter-Glo assay
Antiproliferative activity against human LNCaP C4-2B cells assessed as inhibition of cell growth by Celltiter-Glo assay
|
[PMID: 34962793] |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 2688745-47-1
-
Masse moléculaire 476.50
-
Formule C26H25FN4O4
-
SMILES
O=C(C1=C2C=C(OC)C=CN2C(C(C)=O)=C1)NC3=CC(C(O)C)=CC(C4=CN(C5CC5)N=C4)=C3F
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)